Literature DB >> 26194891

Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in Schizophrenia.

Jared W Young1, Athina Markou2.   

Abstract

Amotivation and reward-processing deficits have long been described in patients with schizophrenia and considered large contributors to patients' inability to integrate well in society. No effective treatments exist for these symptoms, partly because the neuromechanisms mediating such symptoms are poorly understood. Here, we propose a translational neuroscientific approach that can be used to assess reward/motivational deficits related to the negative symptoms of schizophrenia using behavioral paradigms that can also be conducted in experimental animals. By designing and using objective laboratory behavioral tools that are parallel in their parameters in rodents and humans, the neuromechanisms underlying behaviors with relevance to these symptoms of schizophrenia can be investigated. We describe tasks that measure the motivation of rodents to expend physical and cognitive effort to gain rewards, as well as probabilistic learning tasks that assess both reward learning and feedback-based decision making. The latter tasks are relevant because of demonstrated links of performance deficits correlating with negative symptoms in patients with schizophrenia. These tasks utilize operant techniques in order to investigate neural circuits targeting a specific domain across species. These tasks therefore enable the development of insights into altered mechanisms leading to negative symptom-relevant behaviors in patients with schizophrenia. Such findings will then enable the development of targeted treatments for these altered neuromechanisms and behaviors seen in schizophrenia.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 26194891      PMCID: PMC4535652          DOI: 10.1093/schbul/sbv093

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  103 in total

1.  CNTRICS imaging biomarkers selection: Working memory.

Authors:  Deanna M Barch; Holly Moore; Derek E Nee; Dara S Manoach; Steven J Luck
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

Review 2.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

Review 3.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

4.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

5.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

6.  Working memory contributions to reinforcement learning impairments in schizophrenia.

Authors:  Anne G E Collins; Jaime K Brown; James M Gold; James A Waltz; Michael J Frank
Journal:  J Neurosci       Date:  2014-10-08       Impact factor: 6.167

Review 7.  Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.

Authors:  J W Young; M A Geyer
Journal:  J Psychopharmacol       Date:  2014-12-16       Impact factor: 4.153

8.  Association between nicotine withdrawal and reward responsiveness in humans and rats.

Authors:  Michele L Pergadia; Andre Der-Avakian; Athina Markou; Diego A Pizzagalli; Manoranjan S D'Souza; Pamela A F Madden; Andrew C Heath; Saul Shiffman
Journal:  JAMA Psychiatry       Date:  2014-11       Impact factor: 21.596

9.  A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia.

Authors:  Jeffrey A Lieberman; Geoffrey Dunbar; Anthony C Segreti; Ragy R Girgis; Frances Seoane; Jessica S Beaver; Naihua Duan; David A Hosford
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853

10.  Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice.

Authors:  J W Young; M A Geyer; A J Rissling; R F Sharp; L T Eyler; G L Asgaard; G A Light
Journal:  Transl Psychiatry       Date:  2013-11-12       Impact factor: 6.222

View more
  21 in total

Review 1.  Preclinical Models to Investigate Mechanisms of Negative Symptoms in Schizophrenia.

Authors:  Samuel A Barnes; Andre Der-Avakian; Jared W Young
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

2.  The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania.

Authors:  Morgane Milienne-Petiot; James P Kesby; Mary Graves; Jordy van Enkhuizen; Svetlana Semenova; Arpi Minassian; Athina Markou; Mark A Geyer; Jared W Young
Journal:  Neuropharmacology       Date:  2016-10-11       Impact factor: 5.250

Review 3.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

4.  Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms.

Authors:  L Felice Reddy; William P Horan; Deanna M Barch; Robert W Buchanan; Eduardo Dunayevich; James M Gold; Naomi Lyons; Stephen R Marder; Michael T Treadway; Jonathan K Wynn; Jared W Young; Michael F Green
Journal:  Schizophr Bull       Date:  2015-07-03       Impact factor: 9.306

5.  Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: An interim report.

Authors:  Melissa Fisher; Mor Nahum; Elizabeth Howard; Abby Rowlands; Benjamin Brandrett; Amy Kermott; Joshua Woolley; Sophia Vinogradov
Journal:  Psychiatr Rehabil J       Date:  2017-03

6.  Effort-Based Decision Making in Schizophrenia: Evaluation of Paradigms to Measure Motivational Deficits.

Authors:  Michael F Green; William P Horan
Journal:  Schizophr Bull       Date:  2015-06-24       Impact factor: 9.306

7.  5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.

Authors:  Vladimir M Pogorelov; Ramona M Rodriguiz; Jianjun Cheng; Mei Huang; Claire M Schmerberg; Herbert Y Meltzer; Bryan L Roth; Alan P Kozikowski; William C Wetsel
Journal:  Neuropsychopharmacology       Date:  2017-03-15       Impact factor: 7.853

Review 8.  Modelling depression in animals: at the interface of reward and stress pathways.

Authors:  D A Slattery; J F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2017-02-22       Impact factor: 4.530

9.  HIV Transgenic Rats Demonstrate Superior Task Acquisition and Intact Reversal Learning in the Within-Session Probabilistic Reversal Learning Task.

Authors:  Benjamin Z Roberts; Yinong V He; Muhammad Chatha; Arpi Minassian; Igor Grant; Jared W Young
Journal:  Cogn Affect Behav Neurosci       Date:  2021-07-26       Impact factor: 3.282

10.  Relationship between effortful motivation and neurocognition in schizophrenia.

Authors:  Andrew W Bismark; Michael L Thomas; Melissa Tarasenko; Alexandra L Shiluk; Sonia Y Rackelmann; Jared W Young; Gregory A Light
Journal:  Schizophr Res       Date:  2017-06-30       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.